Method for assessing brain changes associated with gluteus maximus activation.

Published

Journal Article

STUDY DESIGN: Reliability study. OBJECTIVES: To determine the feasibility and reliability of using transcranial magnetic stimulation (TMS) to assess corticomotor excitability (CE) of the gluteus maximus. BACKGROUND: Sport-specific skill training targeting greater utilization of the gluteus maximus has been proposed as a method to reduce the incidence of noncontact knee injuries. The use of TMS to assess changes in CE may help to determine training-induced central mechanisms associated with gluteus maximus activation. METHODS: Within- and between-day reliability was measured in 10 healthy adults. The CE was measured by stimulating the gluteus maximus ìhotspotî at 120% and 150% of motor threshold, while subjects performed a double-leg bridge. An intraclass correlation coefficient (model 2,1), standard error of measurement, and minimal detectable change were calculated to determine the within- and between-day reliability for the following TMS variables: peak-to-peak motor-evoked potential (MEP) amplitudes, cortical silent period, and MEP latency. RESULTS: It is feasible to measure the CE of the gluteus maximus with TMS. The intraclass correlation coefficients for all TMS outcome measures ranged from 0.73 to 0.97. The ranges of minimal detectable change, with respect to mean values for each TMS variable, were larger for MEP amplitude (304.7-585.4 µV) compared to those for cortical silent period duration (25.3-40.8 milliseconds) and MEP latency (1.1-2.1 milliseconds). CONCLUSION: The present study demonstrated a feasible method for using TMS to measure CE of the gluteus maximus. Small minimal detectable change values for the cortical silent period and MEP latency provide a reference for future studies.

Full Text

Duke Authors

Cited Authors

  • Fisher, BE; Lee, Y-Y; Pitsch, EA; Moore, B; Southam, A; Faw, TD; Powers, CM

Published Date

  • April 2013

Published In

Volume / Issue

  • 43 / 4

Start / End Page

  • 214 - 221

PubMed ID

  • 23485621

Pubmed Central ID

  • 23485621

Electronic International Standard Serial Number (EISSN)

  • 1938-1344

Digital Object Identifier (DOI)

  • 10.2519/jospt.2013.4188

Language

  • eng

Conference Location

  • United States